Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents

OBJECTIVE: To evaluate the safety of CSL's split‐virion inactivated trivalent 2009 Southern Hemisphere formulation influenza vaccine (TIV) in children. METHODS: We enrolled 1992 healthy children into three groups: Cohorts A, ≥6 months to <3 years; B, ≥3 years to <9 years; and C, ≥9 years...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Stephen B., Chuk, Lai‐man R., Nissen, Michael D., Nolan, Terry M., McVernon, Jodie, Booy, Robert, Heron, Leon, Richmond, Peter C., Walls, Tony, Marshall, Helen S., Reynolds, Graham J., Hartel, Gunter F., Hu, Wilson, Lai, Michael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Part 1
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781200/
https://www.ncbi.nlm.nih.gov/pubmed/23551933
http://dx.doi.org/10.1111/irv.12107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781200/
https://www.ncbi.nlm.nih.gov/pubmed/23551933
http://dx.doi.org/10.1111/irv.12107

Ejemplares similares